Mironid Raises $46 Million to Advance ADPKD Therapy
Glasgow, Scotland, August 5, 2026 Mironid has successfully raised $46 million in a Series B financing round to accelerate...
Capital for New Therapy
AsymBio Secures $184 Million to Expand Global CDMO Growth
Shanghai, China, August 4, 2026 AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem...
CND Life Sciences Secures Growth Funding for Syn-One Test
Scottsdale, Arizona & Boca Raton, Florida, August 4, 2026 CND Life Sciences has announced the successful completion of a...
Trace Biosciences and Axogen Advance Nerve Trace Technology
PORTLAND, Ore., July 29, 2026 Trace Biosciences, Inc. has secured a strategic investment from Axogen, Inc. to accelerate clinical...
Victory Square Updates Hydreight After FDA Peptide Panel Vote
VANCOUVER, BC, July 29, 2026 Victory Square Technologies Inc. has provided an update on Hydreight Technologies and its broader...
Ratio Therapeutics Raises $70 Million to Advance Radiotherapeutics
BOSTON, July 31, 2026 Ratio Therapeutics announced the successful closing of a $70 million Series C financing, increasing the...
CORE Biomedicine Secures $21M Series A Funding
BOSTON, TOKYO and SUZHOU, July 28, 2026 CORE Biomedicine, a biotechnology company advancing lineage-based precision oncology therapeutics, has announced...
Xeltis Raises €20.5M to Advance aXess and US Expansion
EINDHOVEN, The Netherlands, July 28, 2026 Xeltis has raised an additional €20.5 million in funding to accelerate the development...
Estrigenix Therapeutics Secures Seed Funding to Advance ERβ Platform
MILWAUKEE, July 21, 2026 Estrigenix Therapeutics announced the first closing of its $2 million Series Seed financing, led by...
Persephoni Backs SelSym to Advance Trauma Bleeding Care
RESEARCH TRIANGLE PARK, N.C., July 15, 2026 Persephoni BioSciences has announced a strategic investment in SelSym Biotech, bringing the...